title: Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
authors.affiliation: Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil.
authors.forename: Simone
authors.initials: S
authors.lastname: Bonecker
authors.affiliation: Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
authors.forename: Marina
authors.initials: M
authors.lastname: Magnago
authors.affiliation: Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: Jaspal
authors.initials: J
authors.lastname: Kaeda
authors.affiliation: Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
authors.forename: Cristiana
authors.initials: C
authors.lastname: Solza
authors.affiliation: Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. Electronic address: zalcberg@inca.gov.br.
authors.forename: Ilana
authors.initials: I
authors.lastname: Zalcberg Renault
references.citation: Leukemia. 2003 Dec;17(12):2318-57
references.pmid: 14562125
references.citation: Best Pract Res Clin Haematol. 2009 Sep;22(3):355-65
references.pmid: 19959086
references.citation: Blood. 2013 Aug 8;122(6):872-84
references.pmid: 23803709